Our Artificial Intelligence (AI) based technology precisely identifies and matches patients clinical trials in community practices. Our proprietary technology is comprised of:

- Natural Language Processing for medical records, molecular diagnostics test results and clinical trial protocols; oncology proprietary ontology with 50, 000 elements specific to detailed oncology trial pre-screening

- Machine learning technology for scaled pre-screening; prescreening in the matter of seconds instead of hours

- Real world data platform that generates insights for drug discovery and development; thousands of full patient longitudinal journey for rapid insights

- AI powered patient identification technology; patients are found for pre-screening across the globe in the matter of seconds if they are in Massive Bio’s patient and provider network for trials

Home page of this offering   provided by Massive Bio